Experiences of crises in patients with advanced chronic obstructive pulmonary disease (COPD) or lung cancer and their carers - a qualitative interview study

Recruiting

Conditions: J44
C34
Other chronic obstructive pulmonary disease
Malignant neoplasm of bronchus and lung

Registration Number: DRKS00000476

Lead Sponsor: Institut für Palliative Care (ipac) e.V.

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 80

Inclusion Criteria

Patients with the following criteria will be eligible for this study.
The inclusion criteria will be:
1)diagnosis of advanced disease as defined as follows:
Lung cancer: Primary lung cancer at all stages (small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC));
COPD: stage III or IV of the GOLD classification (Global Initiative for Obstructive Lung Disease), which include the airflow limitation measured by spirometry FEV1 < 50%, FEV1/FVC < 0.7 (FEV1: forced expiratory volume in one second; FVC: forced vital capacity) and symptoms such as more severe breathlessness, reduced exercise capacity and repeated exacerbations;
2)age = 18 years.
Disease orientated therapies (chemotherapy, radiotherapy, surgery) can be ongoing.
Carers are people who are close related to the patient and chosen by the patient.

Exclusion Criteria

(1) lack of capacity to give informant consent; (2) lack of capacity to be interviewed;(3)cognitive impairment (clinical judgment by the principal investigator)

Study & Design

Study Type: observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Description of experiences of crises in patients with advanced chronic obstructive pulmonary disease or lung cancer and their caregivers

Secondary Outcome Measures

Name	Time	Method
Demographic data (age, gender, nationality, marital status, children, caregivers, education, smoking status, technical equipment (e.g. internet use)); disease data (disease, stage, comorbidities, lung function and Hb, disease-specific therapies, other therapies (i.e. pain medication), function by Karnofsky Performance Status, number of hospital admissions in the last 12 months)